BioMarin Pharmaceutical



金融业
股票价格
USD
资产
USD 7.59B
现金及等价物
USD 1.31B
销售成本
USD 161.56M
流动资产
USD 3.95B
流动负债
USD 759.03M
债务
USD 604.24M
EBIT
USD 198.39M
EBITDA
USD -5.26M
员工
3.04K
EPS每股收益
USD 0.46
股本和储备
USD 6.09B
销售毛利
USD 713.01M
债务利息支出
USD 2.78M
利息收入
USD 17.85M
贷款资金
USD 597.18M
市值
USD 11.99B
净收入
USD -46.57M
营业费用
USD 676.18M
营业利润
USD 198.39M
普通股股本
USD 192.3M
PE价格收益
USD 19.24
税前利润
USD -26.32M
销售收入
USD 875M
销售和管理费用
USD 322.21M
股票
USD 1.3B
贸易债权人
USD 759.03M
应收帐款人
USD 908.21M


Ebitda 更改 日
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Bayer EUR 1.51B 1.28B 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -5.26M 300.71M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Incyte USD 414.5M 92.42M 2025-12
Insmed USD -314.19M 31.48M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
PTC Therapeutics USD 20.63M 53.74M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 5.66B 3.77B 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
United Therapeutics USD 436.8M 34.2M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


BioMarin Pharmaceutical - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.